title: Estradiol enhances the acquisition of lithium chloride-induced conditioned taste aversion in castrated male rats.
abstract: The present study examined the effects of short-term treatment with ovarian hormones on the acquisition of conditioned taste aversion (CTA). Adult male rats were castrated and randomly divided into LiCl- and saline-treated groups. Nineteen days after castration, all of the animals were subjected to 23.5-h daily water deprivation for seven successive days (day 1 to day 7). On the conditioning day (day 8), the rats received either a 4 ml/kg of 0.15 M LiCl or the same dose of saline injection immediately after administration of a 2 % sucrose solution during the 30-min water session. Starting from day 6, rats in both groups received one of the following treatments: daily subcutaneous injection of (1) estradiol alone (30 μg/kg; estradiol benzoate (E) group), (2) estradiol plus progesterone (500 μg; E + progesterone (P) group), or (3) olive oil. From day 9 to day 11, all of the rats were given daily two-bottle preference tests during the 30-min fluid session. The estradiol and estradiol plus progesterone treatments in the LiCl groups resulted in significantly lower preference scores for the sucrose solution compared with the olive oil treatment groups, but no difference in preference score was seen between these two groups. These results indicate that both the estradiol and estradiol plus progesterone treatments in the LiCl groups enhanced the acquisition of CTA learning and suggest that estradiol affects the acquisition of CTA mediated by an activational effect in male rats, whereas progesterone treatment does not influence the effects of estradiol on the acquisition of CTA.
authors: Department of Physiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
authors: Shih-Fan
authors: SF
authors: Lin
authors: Yuan-Feen
authors: YF
authors: Tsai
authors: Mei-Yun
authors: MY
authors: Tai
authors: Kuei-Ying
authors: KY
authors: Yeh
mesh_terms: D000818:Animals; D004338:Drug Combinations; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology; D018021:Lithium Chloride / Q000633:toxicity*; D008297:Male; D009919:Orchiectomy; D011374:Progesterone / Q000494:pharmacology*; D011897:Random Allocation; D051381:Rats; D013649:Taste / Q000187:drug effects*
chemical_list: D004338:Drug Combinations; D004967:Estrogens; C074283:estradiol 3-benzoate; D011374:Progesterone; D004958:Estradiol; C025370:estradiol benzoate, progesterone drug combination; D018021:Lithium Chloride